KLF9 and Hypoglycemia: Very recently, it was shown that Klf9 induction by synthetic GCs in mouse liver leads to hyperglycemia, while deletion of Klf9 caused hypoglycemia and was protective in a model of GC-induced diabetes (Cui et al., 2019).